StemPoint Capital LP BMY Holdings History

Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$2.87 Mil
% of Total Estimate Gain
22.25%

StemPoint Capital LP's Bristol-Myers Squibb Co Holding Summary

As of 2025-03-31, StemPoint Capital LP held - shares of Bristol-Myers Squibb Co(BMY), totaling N/A. This investment constitutes 0% of their stock portfolio, and StemPoint Capital LP now holds 0% of the outstanding Bristol-Myers Squibb Co(BMY) stock.

The initial trade took place in 2024Q3. And since then StemPoint Capital LP has made 1 purchases of BMY, at an average price of $46.91, for a total of 275,303.00 shares. In addition, there have been 2 sales at an average price of $57.35 for 275,303.00 shares. Based on historical transaction data and BMY's current price of $48.06, StemPoint Capital LP's estimated gain on his BMY holdings is $2.87 Mil, reflecting a 22.25% gain to date.

StemPoint Capital LP BMY ($48.06) Holding Chart

StemPoint Capital LP BMY ($48.06) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1